|
Investigation: visual inspection: the following observations were made during the visual inspection: scratches on the m.Blue housing.Colored peritoneal catheter.Peritoneal catheter connected a piece of catheter with a third- party connector.Permeability test: the test showed that the m.Blue and the peritoneal catheter are permeable.Computer control test: the computer control test showed the opening pressure of the differential unit of the valve, at a reference flow rate of 20 ml/h in a horizontal position of the valve, to be 11.35 cmh2o.This is within the specified tolerance of 10 cmh2o ± 3 cmh2o.Additionally, the gravitational unit of the valve was tested according to standard procedure in the vertical position of the valve.At an opening pressure of 16 cmh2o in the vertical position, a pressure of 16 +6/ -12 cmh2o is expected.The results indicated that at a reference flow of 20 ml/h in the vertical position, the gravitational unit of the m.Blue had a pressure of 13.50 cmh2o.This is within the specified tolerance of 16 +6/ -12 cmh2o.Adjustability test: the m.Blue was found to be not adjustable to specifications.Braking force and brake function test: the braking force test indicates that the brake function of the m.Blue is present.Due to the non-adjustability of the valve, an investigation of the braking force was not possible.Internal inspection of product: in order to verify whether the investigated valve was compromised by the known risks of hydrocephalus therapy, e.G.By a build-up of natural substances (protein, blood, or tissue particles) in the cerebrospinal fluid, the valve is finally opened with a special tool.After dismantling of the valves, deposits were found in m.Blue.Results: based on our investigation results, we have determined that there was a non- adjustability of the valve at the time of our investigation.Detected deposits were the cause of the non- adjustability.Existing deposits in the csf can temporarily impair the function of the valve and is described as concomitant symptoms in hydrocephalus therapy.We can exclude a defect at the time of release.The valve system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
|